Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
Shenmai injection (SMI), as a patented traditional Chinese medicine, is extracted from Panax ginseng and Ophiopogon japonicus. It commonly used in the treatment of cardiovascular disease and in the control of cardiac toxicity induced by doxorubicin (DOX) treatment. However, its anti-cardiotoxicity m...
Saved in:
Main Authors: | Lin Li (Author), Jinghao Li (Author), Qilong Wang (Author), Xin Zhao (Author), Dongli Yang (Author), Lu Niu (Author), Yanze Yang (Author), Xianxian Zheng (Author), Limin Hu (Author), Yuhong Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation
by: Lin Li, et al.
Published: (2020) -
Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
by: Sheng Zhang, et al.
Published: (2019) -
The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy
by: Patrick Kwabena Oduro, et al.
Published: (2022) -
Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis
by: Lili Yang, et al.
Published: (2024) -
Low-dose aspirin for the prevention of preterm birth in nulliparous women: systematic review and meta-analysis
by: Xin Yan, et al.
Published: (2024)